Safety and Immunogenicity Assessment of an Oral Cholera Vaccine through Phase I Clinical Trial in Korea

The safety, tolerability and immunogenicity of an oral cholera vaccine (OCV) was assessed in adult Korean male through an open-label, non-comparative clinical study. Two doses of vaccine with an interval of 2 weeks were given to 20 healthy subjects. A total of 7 adverse events occurred in 6 subjects...

Descripción completa

Detalles Bibliográficos
Autores principales: Baik, Young Ok, Choi, Seuk Keun, Kim, Jae Woo, Yang, Jae Seung, Kim, Ick Young, Kim, Chan Wha, Hong, Jang Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991791/
https://www.ncbi.nlm.nih.gov/pubmed/24753695
http://dx.doi.org/10.3346/jkms.2014.29.4.494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991791/
https://www.ncbi.nlm.nih.gov/pubmed/24753695
http://dx.doi.org/10.3346/jkms.2014.29.4.494

Ejemplares similares